Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, https://tamzincqgn119985.blogdun.com/36908611/tirzepatide-a-promising-new-treatment-for-obesity